Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brundage

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|February 7, 2017
Adjuvant ipilimumab for stage III melanoma: the patient voiceMichael Brundage, Timothy Hanna
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Integrating patient-reported outcomes in healthcare policy, research and practiceClaire Snyder, Michael Brundage
JAMA Oncology|August 25, 2022
Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials-ReplyBishal Gyawali, Elizabeth Eisenhauer, Michael Brundage
Clinical and Translational Radiation Oncology|July 17, 2019
The radiation dose tolerance of the brachial plexus: A systematic review and meta-analysisMichael Yan, Weidong Kong, Andrew Kerr, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2011
A knowledge translation challenge: clinical use of quality of life data from cancer clinical trialsMichael Brundage, Brenda Bass, Ringash Jolie, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2007
Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experienceDavid Osoba, Andrea Bezjak, Michael Brundage, et al.
BJU International|April 17, 2012
Prognostic significance of lymphovascular invasion in radical prostatectomy specimensJonathan Ng, Aamer Mahmud, Brenda Bass, et al.
The Lancet. Oncology|September 3, 2021
Stereotactic body radiotherapy for painful spinal metastases - Authors' replyArjun Sahgal, Michael Brundage, Keyue Ding, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2021
Factors predicting missing instruments in three cancer randomized clinical trialsMichael J Palmer, Harriet Richardson, Dongsheng Tu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian studyJessica Chan, Erika Brown, Kristopher Dennis, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|February 7, 2017
Adjuvant ipilimumab for stage III melanoma: the patient voiceMichael Brundage, Timothy Hanna
Expert Review of Pharmacoeconomics & Outcomes Research|August 19, 2010
Integrating patient-reported outcomes in healthcare policy, research and practiceClaire Snyder, Michael Brundage
JAMA Oncology|August 25, 2022
Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials-ReplyBishal Gyawali, Elizabeth Eisenhauer, Michael Brundage
Clinical and Translational Radiation Oncology|July 17, 2019
The radiation dose tolerance of the brachial plexus: A systematic review and meta-analysisMichael Yan, Weidong Kong, Andrew Kerr, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2011
A knowledge translation challenge: clinical use of quality of life data from cancer clinical trialsMichael Brundage, Brenda Bass, Ringash Jolie, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2007
Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experienceDavid Osoba, Andrea Bezjak, Michael Brundage, et al.
BJU International|April 17, 2012
Prognostic significance of lymphovascular invasion in radical prostatectomy specimensJonathan Ng, Aamer Mahmud, Brenda Bass, et al.
The Lancet. Oncology|September 3, 2021
Stereotactic body radiotherapy for painful spinal metastases - Authors' replyArjun Sahgal, Michael Brundage, Keyue Ding, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 2, 2021
Factors predicting missing instruments in three cancer randomized clinical trialsMichael J Palmer, Harriet Richardson, Dongsheng Tu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 23, 2021
Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian studyJessica Chan, Erika Brown, Kristopher Dennis, et al.
Pageof 16